nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—esophageal cancer—stomach cancer	0.191	0.544	CtDrD
Methotrexate—colon cancer—stomach cancer	0.16	0.455	CtDrD
Methotrexate—TYMS—Floxuridine—stomach cancer	0.1	0.334	CbGbCtD
Methotrexate—TYMS—stomach cancer	0.0905	0.485	CbGaD
Methotrexate—MTHFR—stomach cancer	0.072	0.386	CbGaD
Methotrexate—TYMS—Capecitabine—stomach cancer	0.0316	0.105	CbGbCtD
Methotrexate—ALB—stomach cancer	0.0241	0.129	CbGaD
Methotrexate—MTHFR—Fluorouracil—stomach cancer	0.022	0.0732	CbGbCtD
Methotrexate—TYMS—Fluorouracil—stomach cancer	0.0187	0.0623	CbGbCtD
Methotrexate—ABCC10—Docetaxel—stomach cancer	0.0118	0.0392	CbGbCtD
Methotrexate—ABCC3—Fluorouracil—stomach cancer	0.00972	0.0323	CbGbCtD
Methotrexate—ABCC10—Doxorubicin—stomach cancer	0.0088	0.0293	CbGbCtD
Methotrexate—SLC22A7—Fluorouracil—stomach cancer	0.0076	0.0253	CbGbCtD
Methotrexate—ABCC4—Fluorouracil—stomach cancer	0.00743	0.0247	CbGbCtD
Methotrexate—SLCO1B3—Docetaxel—stomach cancer	0.00659	0.0219	CbGbCtD
Methotrexate—ABCC1—Epirubicin—stomach cancer	0.00639	0.0213	CbGbCtD
Methotrexate—ABCC1—Irinotecan—stomach cancer	0.00622	0.0207	CbGbCtD
Methotrexate—ABCB1—Mitomycin—stomach cancer	0.00585	0.0194	CbGbCtD
Methotrexate—SLC22A7—Docetaxel—stomach cancer	0.0058	0.0193	CbGbCtD
Methotrexate—ABCC3—Doxorubicin—stomach cancer	0.00553	0.0184	CbGbCtD
Methotrexate—SLCO1B1—Irinotecan—stomach cancer	0.00524	0.0174	CbGbCtD
Methotrexate—ABCC2—Irinotecan—stomach cancer	0.0046	0.0153	CbGbCtD
Methotrexate—ABCC1—Docetaxel—stomach cancer	0.00456	0.0152	CbGbCtD
Methotrexate—ABCG2—Irinotecan—stomach cancer	0.00416	0.0138	CbGbCtD
Methotrexate—ABCG2—Fluorouracil—stomach cancer	0.00399	0.0133	CbGbCtD
Methotrexate—ABCC1—Doxorubicin—stomach cancer	0.0034	0.0113	CbGbCtD
Methotrexate—ABCC2—Docetaxel—stomach cancer	0.00337	0.0112	CbGbCtD
Methotrexate—ABCG2—Docetaxel—stomach cancer	0.00305	0.0101	CbGbCtD
Methotrexate—ALB—Irinotecan—stomach cancer	0.00287	0.00954	CbGbCtD
Methotrexate—ALB—Fluorouracil—stomach cancer	0.00275	0.00915	CbGbCtD
Methotrexate—ABCC2—Doxorubicin—stomach cancer	0.00251	0.00836	CbGbCtD
Methotrexate—ABCG2—Doxorubicin—stomach cancer	0.00227	0.00756	CbGbCtD
Methotrexate—ABCB1—Irinotecan—stomach cancer	0.0015	0.00499	CbGbCtD
Methotrexate—ABCC2—bile—stomach cancer	0.00123	0.0359	CbGeAlD
Methotrexate—ABCB1—Docetaxel—stomach cancer	0.0011	0.00366	CbGbCtD
Methotrexate—ABCB1—Doxorubicin—stomach cancer	0.00082	0.00273	CbGbCtD
Methotrexate—FOLR1—hematopoietic system—stomach cancer	0.000768	0.0225	CbGeAlD
Methotrexate—FOLR1—epithelium—stomach cancer	0.000702	0.0205	CbGeAlD
Methotrexate—SLC19A1—hematopoietic system—stomach cancer	0.000674	0.0197	CbGeAlD
Methotrexate—MTHFR—blood vessel—stomach cancer	0.000606	0.0177	CbGeAlD
Methotrexate—TYMS—Paclitaxel—Docetaxel—stomach cancer	0.000565	1	CbGdCrCtD
Methotrexate—FOLR1—lymphoid tissue—stomach cancer	0.000541	0.0158	CbGeAlD
Methotrexate—SLC46A1—hematopoietic system—stomach cancer	0.000519	0.0152	CbGeAlD
Methotrexate—Raltitrexed—TYMS—stomach cancer	0.000491	0.257	CrCbGaD
Methotrexate—SLC19A1—lymphoid tissue—stomach cancer	0.000474	0.0139	CbGeAlD
Methotrexate—SLC19A1—digestive system—stomach cancer	0.000468	0.0137	CbGeAlD
Methotrexate—GGH—smooth muscle tissue—stomach cancer	0.00045	0.0131	CbGeAlD
Methotrexate—FPGS—hematopoietic system—stomach cancer	0.000449	0.0131	CbGeAlD
Methotrexate—FOLR1—endocrine gland—stomach cancer	0.000441	0.0129	CbGeAlD
Methotrexate—AOX1—gall bladder—stomach cancer	0.000436	0.0128	CbGeAlD
Methotrexate—ATIC—hematopoietic system—stomach cancer	0.000434	0.0127	CbGeAlD
Methotrexate—ABCC3—gall bladder—stomach cancer	0.000427	0.0125	CbGeAlD
Methotrexate—ABCC11—endocrine gland—stomach cancer	0.000423	0.0124	CbGeAlD
Methotrexate—GGH—pancreas—stomach cancer	0.000416	0.0122	CbGeAlD
Methotrexate—ATIC—epithelium—stomach cancer	0.000397	0.0116	CbGeAlD
Methotrexate—SLC19A1—endocrine gland—stomach cancer	0.000387	0.0113	CbGeAlD
Methotrexate—ATIC—smooth muscle tissue—stomach cancer	0.000382	0.0112	CbGeAlD
Methotrexate—ABCC11—liver—stomach cancer	0.000382	0.0112	CbGeAlD
Methotrexate—Pralatrexate—TYMS—stomach cancer	0.000372	0.194	CrCbGaD
Methotrexate—Leucovorin—TYMS—stomach cancer	0.000372	0.194	CrCbGaD
Methotrexate—SLC46A1—lymphoid tissue—stomach cancer	0.000365	0.0107	CbGeAlD
Methotrexate—ALB—gall bladder—stomach cancer	0.000364	0.0106	CbGeAlD
Methotrexate—SLC46A1—digestive system—stomach cancer	0.000361	0.0105	CbGeAlD
Methotrexate—GGH—digestive system—stomach cancer	0.000355	0.0104	CbGeAlD
Methotrexate—ATIC—pancreas—stomach cancer	0.000353	0.0103	CbGeAlD
Methotrexate—SLC19A1—liver—stomach cancer	0.000349	0.0102	CbGeAlD
Methotrexate—GGH—bone marrow—stomach cancer	0.000327	0.00957	CbGeAlD
Methotrexate—MTHFR—hematopoietic system—stomach cancer	0.000323	0.00943	CbGeAlD
Methotrexate—FPGS—lymphoid tissue—stomach cancer	0.000316	0.00924	CbGeAlD
Methotrexate—FPGS—digestive system—stomach cancer	0.000312	0.00912	CbGeAlD
Methotrexate—ATIC—lymphoid tissue—stomach cancer	0.000306	0.00893	CbGeAlD
Methotrexate—ATIC—digestive system—stomach cancer	0.000302	0.00882	CbGeAlD
Methotrexate—SLC46A1—endocrine gland—stomach cancer	0.000298	0.00872	CbGeAlD
Methotrexate—Pemetrexed—TYMS—stomach cancer	0.000297	0.155	CrCbGaD
Methotrexate—TYMS—hematopoietic system—stomach cancer	0.000294	0.0086	CbGeAlD
Methotrexate—GGH—endocrine gland—stomach cancer	0.000293	0.00857	CbGeAlD
Methotrexate—DHFR—hematopoietic system—stomach cancer	0.000291	0.00852	CbGeAlD
Methotrexate—SLCO4C1—bone marrow—stomach cancer	0.00029	0.00848	CbGeAlD
Methotrexate—PGD—hematopoietic system—stomach cancer	0.00028	0.00819	CbGeAlD
Methotrexate—SLC46A1—liver—stomach cancer	0.000269	0.00786	CbGeAlD
Methotrexate—SLC19A1—lymph node—stomach cancer	0.000268	0.00782	CbGeAlD
Methotrexate—GGH—liver—stomach cancer	0.000264	0.00773	CbGeAlD
Methotrexate—SLC16A1—hematopoietic system—stomach cancer	0.000262	0.00765	CbGeAlD
Methotrexate—TYMS—smooth muscle tissue—stomach cancer	0.000259	0.00758	CbGeAlD
Methotrexate—FPGS—endocrine gland—stomach cancer	0.000258	0.00754	CbGeAlD
Methotrexate—SLCO1B1—hematopoietic system—stomach cancer	0.000254	0.00744	CbGeAlD
Methotrexate—SLCO1B3—endocrine gland—stomach cancer	0.000253	0.00739	CbGeAlD
Methotrexate—ATIC—endocrine gland—stomach cancer	0.000249	0.00729	CbGeAlD
Methotrexate—PGD—smooth muscle tissue—stomach cancer	0.000247	0.00721	CbGeAlD
Methotrexate—SLC22A11—digestive system—stomach cancer	0.000244	0.00712	CbGeAlD
Methotrexate—ABCC3—hematopoietic system—stomach cancer	0.000241	0.00706	CbGeAlD
Methotrexate—ABCC10—hematopoietic system—stomach cancer	0.00024	0.00702	CbGeAlD
Methotrexate—SLC16A1—epithelium—stomach cancer	0.000239	0.00699	CbGeAlD
Methotrexate—SLC22A7—digestive system—stomach cancer	0.000238	0.00695	CbGeAlD
Methotrexate—SLCO4C1—liver—stomach cancer	0.000235	0.00686	CbGeAlD
Methotrexate—FPGS—liver—stomach cancer	0.000232	0.0068	CbGeAlD
Methotrexate—SLCO1B3—liver—stomach cancer	0.000228	0.00666	CbGeAlD
Methotrexate—MTHFR—lymphoid tissue—stomach cancer	0.000227	0.00664	CbGeAlD
Methotrexate—ATIC—liver—stomach cancer	0.000225	0.00657	CbGeAlD
Methotrexate—MTHFR—digestive system—stomach cancer	0.000224	0.00656	CbGeAlD
Methotrexate—SLCO1C1—endocrine gland—stomach cancer	0.000207	0.00606	CbGeAlD
Methotrexate—TYMS—lymphoid tissue—stomach cancer	0.000207	0.00606	CbGeAlD
Methotrexate—SLCO1A2—hematopoietic system—stomach cancer	0.000207	0.00605	CbGeAlD
Methotrexate—SLC46A1—lymph node—stomach cancer	0.000206	0.00602	CbGeAlD
Methotrexate—DHFR—lymphoid tissue—stomach cancer	0.000205	0.006	CbGeAlD
Methotrexate—TYMS—digestive system—stomach cancer	0.000205	0.00598	CbGeAlD
Methotrexate—GGH—lymph node—stomach cancer	0.000203	0.00593	CbGeAlD
Methotrexate—DHFR—digestive system—stomach cancer	0.000203	0.00592	CbGeAlD
Methotrexate—SLC22A11—endocrine gland—stomach cancer	0.000201	0.00589	CbGeAlD
Methotrexate—AOX1—pancreas—stomach cancer	0.000201	0.00588	CbGeAlD
Methotrexate—ABCC4—hematopoietic system—stomach cancer	0.000199	0.00583	CbGeAlD
Methotrexate—SLC22A8—hematopoietic system—stomach cancer	0.000198	0.00578	CbGeAlD
Methotrexate—PGD—lymphoid tissue—stomach cancer	0.000197	0.00577	CbGeAlD
Methotrexate—SLC22A7—endocrine gland—stomach cancer	0.000197	0.00575	CbGeAlD
Methotrexate—PGD—digestive system—stomach cancer	0.000195	0.0057	CbGeAlD
Methotrexate—Tetrahydrofolic acid—MTHFR—stomach cancer	0.000191	0.0997	CrCbGaD
Methotrexate—Folic Acid—MTHFR—stomach cancer	0.000191	0.0997	CrCbGaD
Methotrexate—TYMS—bone marrow—stomach cancer	0.000189	0.00552	CbGeAlD
Methotrexate—DHFR—bone marrow—stomach cancer	0.000187	0.00546	CbGeAlD
Methotrexate—MTHFR—endocrine gland—stomach cancer	0.000185	0.00542	CbGeAlD
Methotrexate—SLCO3A1—endocrine gland—stomach cancer	0.000182	0.00533	CbGeAlD
Methotrexate—SLC16A1—digestive system—stomach cancer	0.000182	0.00532	CbGeAlD
Methotrexate—SLC22A11—liver—stomach cancer	0.000182	0.00531	CbGeAlD
Methotrexate—PGD—bone marrow—stomach cancer	0.00018	0.00525	CbGeAlD
Methotrexate—FPGS—lymph node—stomach cancer	0.000178	0.00521	CbGeAlD
Methotrexate—SLC22A7—liver—stomach cancer	0.000177	0.00518	CbGeAlD
Methotrexate—SLCO1B1—digestive system—stomach cancer	0.000177	0.00517	CbGeAlD
Methotrexate—ATIC—lymph node—stomach cancer	0.000172	0.00504	CbGeAlD
Methotrexate—AOX1—digestive system—stomach cancer	0.000172	0.00502	CbGeAlD
Methotrexate—TYMS—endocrine gland—stomach cancer	0.000169	0.00494	CbGeAlD
Methotrexate—ABCC10—lymphoid tissue—stomach cancer	0.000169	0.00494	CbGeAlD
Methotrexate—ABCC3—digestive system—stomach cancer	0.000168	0.00491	CbGeAlD
Methotrexate—DHFR—endocrine gland—stomach cancer	0.000167	0.0049	CbGeAlD
Methotrexate—MTHFR—liver—stomach cancer	0.000167	0.00489	CbGeAlD
Methotrexate—ABCC10—digestive system—stomach cancer	0.000167	0.00488	CbGeAlD
Methotrexate—SLCO3A1—liver—stomach cancer	0.000164	0.00481	CbGeAlD
Methotrexate—ABCC4—pancreas—stomach cancer	0.000162	0.00474	CbGeAlD
Methotrexate—PGD—endocrine gland—stomach cancer	0.000161	0.00471	CbGeAlD
Methotrexate—ABCC10—bone marrow—stomach cancer	0.000154	0.0045	CbGeAlD
Methotrexate—TYMS—liver—stomach cancer	0.000152	0.00446	CbGeAlD
Methotrexate—DHFR—liver—stomach cancer	0.000151	0.00441	CbGeAlD
Methotrexate—SLC16A1—endocrine gland—stomach cancer	0.00015	0.00439	CbGeAlD
Methotrexate—SLCO1B1—endocrine gland—stomach cancer	0.000146	0.00427	CbGeAlD
Methotrexate—PGD—liver—stomach cancer	0.000145	0.00424	CbGeAlD
Methotrexate—SLCO1A2—digestive system—stomach cancer	0.000144	0.00421	CbGeAlD
Methotrexate—SLCO1C1—lymph node—stomach cancer	0.000143	0.00419	CbGeAlD
Methotrexate—AOX1—endocrine gland—stomach cancer	0.000142	0.00415	CbGeAlD
Methotrexate—ABCC3—endocrine gland—stomach cancer	0.000139	0.00406	CbGeAlD
Methotrexate—ABCC4—digestive system—stomach cancer	0.000139	0.00405	CbGeAlD
Methotrexate—ABCC10—endocrine gland—stomach cancer	0.000138	0.00404	CbGeAlD
Methotrexate—SLC16A1—liver—stomach cancer	0.000136	0.00396	CbGeAlD
Methotrexate—ABCC2—digestive system—stomach cancer	0.000134	0.00392	CbGeAlD
Methotrexate—SLCO1B1—liver—stomach cancer	0.000132	0.00385	CbGeAlD
Methotrexate—ABCB1—blood vessel—stomach cancer	0.00013	0.00381	CbGeAlD
Methotrexate—MTHFR—lymph node—stomach cancer	0.000128	0.00375	CbGeAlD
Methotrexate—AOX1—liver—stomach cancer	0.000128	0.00374	CbGeAlD
Methotrexate—ABCC4—bone marrow—stomach cancer	0.000128	0.00373	CbGeAlD
Methotrexate—SLCO3A1—lymph node—stomach cancer	0.000126	0.00369	CbGeAlD
Methotrexate—ABCC3—liver—stomach cancer	0.000125	0.00366	CbGeAlD
Methotrexate—ABCC10—liver—stomach cancer	0.000124	0.00364	CbGeAlD
Methotrexate—SLCO1A2—endocrine gland—stomach cancer	0.000119	0.00348	CbGeAlD
Methotrexate—TYMS—lymph node—stomach cancer	0.000117	0.00342	CbGeAlD
Methotrexate—DHFR—lymph node—stomach cancer	0.000116	0.00338	CbGeAlD
Methotrexate—ABCC4—endocrine gland—stomach cancer	0.000115	0.00335	CbGeAlD
Methotrexate—PGD—lymph node—stomach cancer	0.000111	0.00325	CbGeAlD
Methotrexate—ABCC2—endocrine gland—stomach cancer	0.000111	0.00324	CbGeAlD
Methotrexate—SLCO1A2—liver—stomach cancer	0.000107	0.00314	CbGeAlD
Methotrexate—ALB—liver—stomach cancer	0.000107	0.00312	CbGeAlD
Methotrexate—SLC16A1—lymph node—stomach cancer	0.000104	0.00304	CbGeAlD
Methotrexate—ABCC4—liver—stomach cancer	0.000103	0.00302	CbGeAlD
Methotrexate—ABCC2—liver—stomach cancer	9.99e-05	0.00292	CbGeAlD
Methotrexate—AOX1—lymph node—stomach cancer	9.8e-05	0.00287	CbGeAlD
Methotrexate—ABCC3—lymph node—stomach cancer	9.59e-05	0.0028	CbGeAlD
Methotrexate—ABCC10—lymph node—stomach cancer	9.54e-05	0.00279	CbGeAlD
Methotrexate—ABCG2—bone marrow—stomach cancer	9.02e-05	0.00264	CbGeAlD
Methotrexate—ABCC1—liver—stomach cancer	8.8e-05	0.00257	CbGeAlD
Methotrexate—ALB—lymph node—stomach cancer	8.18e-05	0.00239	CbGeAlD
Methotrexate—ABCC4—lymph node—stomach cancer	7.92e-05	0.00231	CbGeAlD
Methotrexate—ABCC2—lymph node—stomach cancer	7.66e-05	0.00224	CbGeAlD
Methotrexate—ABCG2—liver—stomach cancer	7.29e-05	0.00213	CbGeAlD
Methotrexate—ABCB1—hematopoietic system—stomach cancer	6.94e-05	0.00203	CbGeAlD
Methotrexate—ABCC1—lymph node—stomach cancer	6.75e-05	0.00197	CbGeAlD
Methotrexate—ABCB1—epithelium—stomach cancer	6.34e-05	0.00185	CbGeAlD
Methotrexate—ABCB1—pancreas—stomach cancer	5.65e-05	0.00165	CbGeAlD
Methotrexate—ABCG2—lymph node—stomach cancer	5.59e-05	0.00163	CbGeAlD
Methotrexate—ABCB1—lymphoid tissue—stomach cancer	4.88e-05	0.00143	CbGeAlD
Methotrexate—ABCB1—digestive system—stomach cancer	4.82e-05	0.00141	CbGeAlD
Methotrexate—ABCB1—bone marrow—stomach cancer	4.45e-05	0.0013	CbGeAlD
Methotrexate—ABCB1—endocrine gland—stomach cancer	3.99e-05	0.00117	CbGeAlD
Methotrexate—ABCB1—liver—stomach cancer	3.59e-05	0.00105	CbGeAlD
Methotrexate—Pancytopenia—Doxorubicin—stomach cancer	2.8e-05	0.000397	CcSEcCtD
Methotrexate—Renal failure—Epirubicin—stomach cancer	2.8e-05	0.000396	CcSEcCtD
Methotrexate—Asthenia—Irinotecan—stomach cancer	2.79e-05	0.000395	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	2.79e-05	0.000394	CcSEcCtD
Methotrexate—Cough—Capecitabine—stomach cancer	2.79e-05	0.000394	CcSEcCtD
Methotrexate—Stomatitis—Epirubicin—stomach cancer	2.77e-05	0.000392	CcSEcCtD
Methotrexate—Conjunctivitis—Epirubicin—stomach cancer	2.77e-05	0.000391	CcSEcCtD
Methotrexate—Neutropenia—Doxorubicin—stomach cancer	2.76e-05	0.000391	CcSEcCtD
Methotrexate—Dysuria—Doxorubicin—stomach cancer	2.76e-05	0.000391	CcSEcCtD
Methotrexate—ABCB1—lymph node—stomach cancer	2.76e-05	0.000806	CbGeAlD
Methotrexate—Hypersensitivity—Fluorouracil—stomach cancer	2.75e-05	0.000389	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Doxorubicin—stomach cancer	2.75e-05	0.000388	CcSEcCtD
Methotrexate—Sweating—Epirubicin—stomach cancer	2.73e-05	0.000386	CcSEcCtD
Methotrexate—Chest pain—Capecitabine—stomach cancer	2.72e-05	0.000384	CcSEcCtD
Methotrexate—Myalgia—Capecitabine—stomach cancer	2.72e-05	0.000384	CcSEcCtD
Methotrexate—Arthralgia—Capecitabine—stomach cancer	2.72e-05	0.000384	CcSEcCtD
Methotrexate—Haematuria—Epirubicin—stomach cancer	2.71e-05	0.000384	CcSEcCtD
Methotrexate—Confusional state—Docetaxel—stomach cancer	2.71e-05	0.000384	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	2.7e-05	0.000382	CcSEcCtD
Methotrexate—Photosensitivity reaction—Doxorubicin—stomach cancer	2.7e-05	0.000381	CcSEcCtD
Methotrexate—Hepatobiliary disease—Epirubicin—stomach cancer	2.69e-05	0.000381	CcSEcCtD
Methotrexate—Anaphylactic shock—Docetaxel—stomach cancer	2.69e-05	0.000381	CcSEcCtD
Methotrexate—Discomfort—Capecitabine—stomach cancer	2.69e-05	0.00038	CcSEcCtD
Methotrexate—Epistaxis—Epirubicin—stomach cancer	2.68e-05	0.00038	CcSEcCtD
Methotrexate—Infection—Docetaxel—stomach cancer	2.67e-05	0.000378	CcSEcCtD
Methotrexate—Diarrhoea—Irinotecan—stomach cancer	2.66e-05	0.000377	CcSEcCtD
Methotrexate—Agranulocytosis—Epirubicin—stomach cancer	2.66e-05	0.000376	CcSEcCtD
Methotrexate—Pneumonia—Doxorubicin—stomach cancer	2.65e-05	0.000375	CcSEcCtD
Methotrexate—Nervous system disorder—Docetaxel—stomach cancer	2.64e-05	0.000373	CcSEcCtD
Methotrexate—Pruritus—Fluorouracil—stomach cancer	2.64e-05	0.000373	CcSEcCtD
Methotrexate—Thrombocytopenia—Docetaxel—stomach cancer	2.64e-05	0.000373	CcSEcCtD
Methotrexate—Infestation—Doxorubicin—stomach cancer	2.63e-05	0.000372	CcSEcCtD
Methotrexate—Infestation NOS—Doxorubicin—stomach cancer	2.63e-05	0.000372	CcSEcCtD
Methotrexate—Drowsiness—Doxorubicin—stomach cancer	2.63e-05	0.000372	CcSEcCtD
Methotrexate—Confusional state—Capecitabine—stomach cancer	2.63e-05	0.000372	CcSEcCtD
Methotrexate—Skin disorder—Docetaxel—stomach cancer	2.61e-05	0.00037	CcSEcCtD
Methotrexate—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	2.61e-05	0.000369	CcSEcCtD
Methotrexate—Renal failure—Doxorubicin—stomach cancer	2.59e-05	0.000366	CcSEcCtD
Methotrexate—Infection—Capecitabine—stomach cancer	2.59e-05	0.000366	CcSEcCtD
Methotrexate—Dizziness—Irinotecan—stomach cancer	2.57e-05	0.000364	CcSEcCtD
Methotrexate—Haemoglobin—Epirubicin—stomach cancer	2.57e-05	0.000363	CcSEcCtD
Methotrexate—Stomatitis—Doxorubicin—stomach cancer	2.57e-05	0.000363	CcSEcCtD
Methotrexate—Anorexia—Docetaxel—stomach cancer	2.57e-05	0.000363	CcSEcCtD
Methotrexate—Conjunctivitis—Doxorubicin—stomach cancer	2.56e-05	0.000362	CcSEcCtD
Methotrexate—Nervous system disorder—Capecitabine—stomach cancer	2.56e-05	0.000361	CcSEcCtD
Methotrexate—Haemorrhage—Epirubicin—stomach cancer	2.56e-05	0.000361	CcSEcCtD
Methotrexate—Hepatitis—Epirubicin—stomach cancer	2.56e-05	0.000361	CcSEcCtD
Methotrexate—Diarrhoea—Fluorouracil—stomach cancer	2.55e-05	0.000361	CcSEcCtD
Methotrexate—Thrombocytopenia—Capecitabine—stomach cancer	2.55e-05	0.000361	CcSEcCtD
Methotrexate—Pharyngitis—Epirubicin—stomach cancer	2.54e-05	0.000359	CcSEcCtD
Methotrexate—Skin disorder—Capecitabine—stomach cancer	2.53e-05	0.000358	CcSEcCtD
Methotrexate—Sweating—Doxorubicin—stomach cancer	2.52e-05	0.000357	CcSEcCtD
Methotrexate—Urinary tract disorder—Epirubicin—stomach cancer	2.52e-05	0.000357	CcSEcCtD
Methotrexate—Hyperhidrosis—Capecitabine—stomach cancer	2.52e-05	0.000356	CcSEcCtD
Methotrexate—Hypotension—Docetaxel—stomach cancer	2.51e-05	0.000356	CcSEcCtD
Methotrexate—Haematuria—Doxorubicin—stomach cancer	2.51e-05	0.000355	CcSEcCtD
Methotrexate—Urethral disorder—Epirubicin—stomach cancer	2.5e-05	0.000354	CcSEcCtD
Methotrexate—Hepatobiliary disease—Doxorubicin—stomach cancer	2.49e-05	0.000352	CcSEcCtD
Methotrexate—Epistaxis—Doxorubicin—stomach cancer	2.48e-05	0.000351	CcSEcCtD
Methotrexate—Anorexia—Capecitabine—stomach cancer	2.48e-05	0.000351	CcSEcCtD
Methotrexate—Vomiting—Irinotecan—stomach cancer	2.48e-05	0.00035	CcSEcCtD
Methotrexate—Dizziness—Fluorouracil—stomach cancer	2.47e-05	0.000349	CcSEcCtD
Methotrexate—Visual impairment—Epirubicin—stomach cancer	2.46e-05	0.000348	CcSEcCtD
Methotrexate—Agranulocytosis—Doxorubicin—stomach cancer	2.46e-05	0.000348	CcSEcCtD
Methotrexate—Rash—Irinotecan—stomach cancer	2.45e-05	0.000347	CcSEcCtD
Methotrexate—Dermatitis—Irinotecan—stomach cancer	2.45e-05	0.000347	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Docetaxel—stomach cancer	2.45e-05	0.000347	CcSEcCtD
Methotrexate—Headache—Irinotecan—stomach cancer	2.44e-05	0.000345	CcSEcCtD
Methotrexate—Hypotension—Capecitabine—stomach cancer	2.43e-05	0.000344	CcSEcCtD
Methotrexate—Insomnia—Docetaxel—stomach cancer	2.43e-05	0.000344	CcSEcCtD
Methotrexate—Paraesthesia—Docetaxel—stomach cancer	2.42e-05	0.000342	CcSEcCtD
Methotrexate—Erythema multiforme—Epirubicin—stomach cancer	2.42e-05	0.000342	CcSEcCtD
Methotrexate—Dyspnoea—Docetaxel—stomach cancer	2.4e-05	0.000339	CcSEcCtD
Methotrexate—Somnolence—Docetaxel—stomach cancer	2.39e-05	0.000338	CcSEcCtD
Methotrexate—Eye disorder—Epirubicin—stomach cancer	2.39e-05	0.000338	CcSEcCtD
Methotrexate—Tinnitus—Epirubicin—stomach cancer	2.38e-05	0.000337	CcSEcCtD
Methotrexate—Haemoglobin—Doxorubicin—stomach cancer	2.38e-05	0.000336	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Capecitabine—stomach cancer	2.37e-05	0.000336	CcSEcCtD
Methotrexate—Cardiac disorder—Epirubicin—stomach cancer	2.37e-05	0.000335	CcSEcCtD
Methotrexate—Vomiting—Fluorouracil—stomach cancer	2.37e-05	0.000335	CcSEcCtD
Methotrexate—Dyspepsia—Docetaxel—stomach cancer	2.37e-05	0.000335	CcSEcCtD
Methotrexate—Hepatitis—Doxorubicin—stomach cancer	2.36e-05	0.000334	CcSEcCtD
Methotrexate—Haemorrhage—Doxorubicin—stomach cancer	2.36e-05	0.000334	CcSEcCtD
Methotrexate—Insomnia—Capecitabine—stomach cancer	2.36e-05	0.000333	CcSEcCtD
Methotrexate—Rash—Fluorouracil—stomach cancer	2.35e-05	0.000333	CcSEcCtD
Methotrexate—Dermatitis—Fluorouracil—stomach cancer	2.35e-05	0.000332	CcSEcCtD
Methotrexate—Pharyngitis—Doxorubicin—stomach cancer	2.35e-05	0.000332	CcSEcCtD
Methotrexate—Paraesthesia—Capecitabine—stomach cancer	2.34e-05	0.000331	CcSEcCtD
Methotrexate—Decreased appetite—Docetaxel—stomach cancer	2.34e-05	0.000331	CcSEcCtD
Methotrexate—Headache—Fluorouracil—stomach cancer	2.34e-05	0.00033	CcSEcCtD
Methotrexate—Urinary tract disorder—Doxorubicin—stomach cancer	2.33e-05	0.00033	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Docetaxel—stomach cancer	2.32e-05	0.000329	CcSEcCtD
Methotrexate—Dyspnoea—Capecitabine—stomach cancer	2.32e-05	0.000329	CcSEcCtD
Methotrexate—Fatigue—Docetaxel—stomach cancer	2.32e-05	0.000328	CcSEcCtD
Methotrexate—Angiopathy—Epirubicin—stomach cancer	2.32e-05	0.000328	CcSEcCtD
Methotrexate—Urethral disorder—Doxorubicin—stomach cancer	2.32e-05	0.000328	CcSEcCtD
Methotrexate—Nausea—Irinotecan—stomach cancer	2.31e-05	0.000327	CcSEcCtD
Methotrexate—Immune system disorder—Epirubicin—stomach cancer	2.31e-05	0.000326	CcSEcCtD
Methotrexate—Mediastinal disorder—Epirubicin—stomach cancer	2.3e-05	0.000326	CcSEcCtD
Methotrexate—Pain—Docetaxel—stomach cancer	2.3e-05	0.000326	CcSEcCtD
Methotrexate—Dyspepsia—Capecitabine—stomach cancer	2.29e-05	0.000324	CcSEcCtD
Methotrexate—Chills—Epirubicin—stomach cancer	2.29e-05	0.000324	CcSEcCtD
Methotrexate—Visual impairment—Doxorubicin—stomach cancer	2.28e-05	0.000322	CcSEcCtD
Methotrexate—Decreased appetite—Capecitabine—stomach cancer	2.27e-05	0.00032	CcSEcCtD
Methotrexate—Alopecia—Epirubicin—stomach cancer	2.26e-05	0.000319	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Capecitabine—stomach cancer	2.25e-05	0.000318	CcSEcCtD
Methotrexate—Fatigue—Capecitabine—stomach cancer	2.25e-05	0.000318	CcSEcCtD
Methotrexate—Mental disorder—Epirubicin—stomach cancer	2.24e-05	0.000317	CcSEcCtD
Methotrexate—Erythema multiforme—Doxorubicin—stomach cancer	2.24e-05	0.000316	CcSEcCtD
Methotrexate—Pain—Capecitabine—stomach cancer	2.23e-05	0.000315	CcSEcCtD
Methotrexate—Malnutrition—Epirubicin—stomach cancer	2.22e-05	0.000315	CcSEcCtD
Methotrexate—Erythema—Epirubicin—stomach cancer	2.22e-05	0.000315	CcSEcCtD
Methotrexate—Feeling abnormal—Docetaxel—stomach cancer	2.22e-05	0.000314	CcSEcCtD
Methotrexate—Nausea—Fluorouracil—stomach cancer	2.21e-05	0.000313	CcSEcCtD
Methotrexate—Eye disorder—Doxorubicin—stomach cancer	2.21e-05	0.000312	CcSEcCtD
Methotrexate—Tinnitus—Doxorubicin—stomach cancer	2.2e-05	0.000312	CcSEcCtD
Methotrexate—Gastrointestinal pain—Docetaxel—stomach cancer	2.2e-05	0.000311	CcSEcCtD
Methotrexate—Cardiac disorder—Doxorubicin—stomach cancer	2.19e-05	0.00031	CcSEcCtD
Methotrexate—Dysgeusia—Epirubicin—stomach cancer	2.18e-05	0.000308	CcSEcCtD
Methotrexate—Back pain—Epirubicin—stomach cancer	2.15e-05	0.000304	CcSEcCtD
Methotrexate—Feeling abnormal—Capecitabine—stomach cancer	2.15e-05	0.000304	CcSEcCtD
Methotrexate—Angiopathy—Doxorubicin—stomach cancer	2.14e-05	0.000303	CcSEcCtD
Methotrexate—Immune system disorder—Doxorubicin—stomach cancer	2.14e-05	0.000302	CcSEcCtD
Methotrexate—Gastrointestinal pain—Capecitabine—stomach cancer	2.13e-05	0.000301	CcSEcCtD
Methotrexate—Mediastinal disorder—Doxorubicin—stomach cancer	2.13e-05	0.000301	CcSEcCtD
Methotrexate—Body temperature increased—Docetaxel—stomach cancer	2.13e-05	0.000301	CcSEcCtD
Methotrexate—Abdominal pain—Docetaxel—stomach cancer	2.13e-05	0.000301	CcSEcCtD
Methotrexate—Chills—Doxorubicin—stomach cancer	2.12e-05	0.0003	CcSEcCtD
Methotrexate—Vision blurred—Epirubicin—stomach cancer	2.1e-05	0.000296	CcSEcCtD
Methotrexate—Alopecia—Doxorubicin—stomach cancer	2.09e-05	0.000295	CcSEcCtD
Methotrexate—Mental disorder—Doxorubicin—stomach cancer	2.07e-05	0.000293	CcSEcCtD
Methotrexate—Urticaria—Capecitabine—stomach cancer	2.07e-05	0.000293	CcSEcCtD
Methotrexate—Ill-defined disorder—Epirubicin—stomach cancer	2.06e-05	0.000292	CcSEcCtD
Methotrexate—Abdominal pain—Capecitabine—stomach cancer	2.06e-05	0.000291	CcSEcCtD
Methotrexate—Body temperature increased—Capecitabine—stomach cancer	2.06e-05	0.000291	CcSEcCtD
Methotrexate—Malnutrition—Doxorubicin—stomach cancer	2.06e-05	0.000291	CcSEcCtD
Methotrexate—Erythema—Doxorubicin—stomach cancer	2.06e-05	0.000291	CcSEcCtD
Methotrexate—Anaemia—Epirubicin—stomach cancer	2.06e-05	0.000291	CcSEcCtD
Methotrexate—Dysgeusia—Doxorubicin—stomach cancer	2.02e-05	0.000285	CcSEcCtD
Methotrexate—Malaise—Epirubicin—stomach cancer	2.01e-05	0.000284	CcSEcCtD
Methotrexate—Vertigo—Epirubicin—stomach cancer	2e-05	0.000283	CcSEcCtD
Methotrexate—Leukopenia—Epirubicin—stomach cancer	1.99e-05	0.000282	CcSEcCtD
Methotrexate—Back pain—Doxorubicin—stomach cancer	1.99e-05	0.000282	CcSEcCtD
Methotrexate—Hypersensitivity—Docetaxel—stomach cancer	1.98e-05	0.00028	CcSEcCtD
Methotrexate—Cough—Epirubicin—stomach cancer	1.94e-05	0.000275	CcSEcCtD
Methotrexate—Vision blurred—Doxorubicin—stomach cancer	1.94e-05	0.000274	CcSEcCtD
Methotrexate—Asthenia—Docetaxel—stomach cancer	1.93e-05	0.000273	CcSEcCtD
Methotrexate—Convulsion—Epirubicin—stomach cancer	1.93e-05	0.000273	CcSEcCtD
Methotrexate—Hypersensitivity—Capecitabine—stomach cancer	1.92e-05	0.000272	CcSEcCtD
Methotrexate—Ill-defined disorder—Doxorubicin—stomach cancer	1.91e-05	0.00027	CcSEcCtD
Methotrexate—Pruritus—Docetaxel—stomach cancer	1.9e-05	0.000269	CcSEcCtD
Methotrexate—Anaemia—Doxorubicin—stomach cancer	1.9e-05	0.000269	CcSEcCtD
Methotrexate—Myalgia—Epirubicin—stomach cancer	1.89e-05	0.000268	CcSEcCtD
Methotrexate—Arthralgia—Epirubicin—stomach cancer	1.89e-05	0.000268	CcSEcCtD
Methotrexate—Chest pain—Epirubicin—stomach cancer	1.89e-05	0.000268	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	1.88e-05	0.000266	CcSEcCtD
Methotrexate—Discomfort—Epirubicin—stomach cancer	1.87e-05	0.000265	CcSEcCtD
Methotrexate—Asthenia—Capecitabine—stomach cancer	1.87e-05	0.000264	CcSEcCtD
Methotrexate—Malaise—Doxorubicin—stomach cancer	1.86e-05	0.000263	CcSEcCtD
Methotrexate—Vertigo—Doxorubicin—stomach cancer	1.85e-05	0.000262	CcSEcCtD
Methotrexate—Pruritus—Capecitabine—stomach cancer	1.84e-05	0.000261	CcSEcCtD
Methotrexate—Leukopenia—Doxorubicin—stomach cancer	1.84e-05	0.000261	CcSEcCtD
Methotrexate—Diarrhoea—Docetaxel—stomach cancer	1.84e-05	0.00026	CcSEcCtD
Methotrexate—Confusional state—Epirubicin—stomach cancer	1.83e-05	0.000259	CcSEcCtD
Methotrexate—Anaphylactic shock—Epirubicin—stomach cancer	1.82e-05	0.000257	CcSEcCtD
Methotrexate—Infection—Epirubicin—stomach cancer	1.8e-05	0.000255	CcSEcCtD
Methotrexate—Cough—Doxorubicin—stomach cancer	1.8e-05	0.000254	CcSEcCtD
Methotrexate—Convulsion—Doxorubicin—stomach cancer	1.78e-05	0.000252	CcSEcCtD
Methotrexate—Diarrhoea—Capecitabine—stomach cancer	1.78e-05	0.000252	CcSEcCtD
Methotrexate—Nervous system disorder—Epirubicin—stomach cancer	1.78e-05	0.000252	CcSEcCtD
Methotrexate—Dizziness—Docetaxel—stomach cancer	1.78e-05	0.000252	CcSEcCtD
Methotrexate—Thrombocytopenia—Epirubicin—stomach cancer	1.78e-05	0.000251	CcSEcCtD
Methotrexate—Skin disorder—Epirubicin—stomach cancer	1.76e-05	0.000249	CcSEcCtD
Methotrexate—Hyperhidrosis—Epirubicin—stomach cancer	1.75e-05	0.000248	CcSEcCtD
Methotrexate—Arthralgia—Doxorubicin—stomach cancer	1.75e-05	0.000248	CcSEcCtD
Methotrexate—Chest pain—Doxorubicin—stomach cancer	1.75e-05	0.000248	CcSEcCtD
Methotrexate—Myalgia—Doxorubicin—stomach cancer	1.75e-05	0.000248	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	1.74e-05	0.000246	CcSEcCtD
Methotrexate—Discomfort—Doxorubicin—stomach cancer	1.73e-05	0.000245	CcSEcCtD
Methotrexate—Anorexia—Epirubicin—stomach cancer	1.73e-05	0.000245	CcSEcCtD
Methotrexate—Dizziness—Capecitabine—stomach cancer	1.72e-05	0.000244	CcSEcCtD
Methotrexate—Vomiting—Docetaxel—stomach cancer	1.71e-05	0.000242	CcSEcCtD
Methotrexate—Rash—Docetaxel—stomach cancer	1.7e-05	0.00024	CcSEcCtD
Methotrexate—Hypotension—Epirubicin—stomach cancer	1.7e-05	0.00024	CcSEcCtD
Methotrexate—Dermatitis—Docetaxel—stomach cancer	1.7e-05	0.00024	CcSEcCtD
Methotrexate—Confusional state—Doxorubicin—stomach cancer	1.69e-05	0.00024	CcSEcCtD
Methotrexate—Headache—Docetaxel—stomach cancer	1.69e-05	0.000238	CcSEcCtD
Methotrexate—Anaphylactic shock—Doxorubicin—stomach cancer	1.68e-05	0.000238	CcSEcCtD
Methotrexate—Infection—Doxorubicin—stomach cancer	1.67e-05	0.000236	CcSEcCtD
Methotrexate—Vomiting—Capecitabine—stomach cancer	1.66e-05	0.000234	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Epirubicin—stomach cancer	1.65e-05	0.000234	CcSEcCtD
Methotrexate—Nervous system disorder—Doxorubicin—stomach cancer	1.65e-05	0.000233	CcSEcCtD
Methotrexate—Thrombocytopenia—Doxorubicin—stomach cancer	1.64e-05	0.000233	CcSEcCtD
Methotrexate—Rash—Capecitabine—stomach cancer	1.64e-05	0.000232	CcSEcCtD
Methotrexate—Insomnia—Epirubicin—stomach cancer	1.64e-05	0.000232	CcSEcCtD
Methotrexate—Dermatitis—Capecitabine—stomach cancer	1.64e-05	0.000232	CcSEcCtD
Methotrexate—Headache—Capecitabine—stomach cancer	1.63e-05	0.000231	CcSEcCtD
Methotrexate—Skin disorder—Doxorubicin—stomach cancer	1.63e-05	0.000231	CcSEcCtD
Methotrexate—Paraesthesia—Epirubicin—stomach cancer	1.63e-05	0.000231	CcSEcCtD
Methotrexate—Hyperhidrosis—Doxorubicin—stomach cancer	1.62e-05	0.00023	CcSEcCtD
Methotrexate—Dyspnoea—Epirubicin—stomach cancer	1.62e-05	0.000229	CcSEcCtD
Methotrexate—Somnolence—Epirubicin—stomach cancer	1.61e-05	0.000228	CcSEcCtD
Methotrexate—Anorexia—Doxorubicin—stomach cancer	1.6e-05	0.000226	CcSEcCtD
Methotrexate—Nausea—Docetaxel—stomach cancer	1.6e-05	0.000226	CcSEcCtD
Methotrexate—Dyspepsia—Epirubicin—stomach cancer	1.6e-05	0.000226	CcSEcCtD
Methotrexate—Decreased appetite—Epirubicin—stomach cancer	1.58e-05	0.000223	CcSEcCtD
Methotrexate—Hypotension—Doxorubicin—stomach cancer	1.57e-05	0.000222	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Epirubicin—stomach cancer	1.57e-05	0.000222	CcSEcCtD
Methotrexate—Fatigue—Epirubicin—stomach cancer	1.57e-05	0.000221	CcSEcCtD
Methotrexate—Pain—Epirubicin—stomach cancer	1.55e-05	0.00022	CcSEcCtD
Methotrexate—Nausea—Capecitabine—stomach cancer	1.55e-05	0.000219	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	1.53e-05	0.000216	CcSEcCtD
Methotrexate—Insomnia—Doxorubicin—stomach cancer	1.52e-05	0.000215	CcSEcCtD
Methotrexate—Paraesthesia—Doxorubicin—stomach cancer	1.51e-05	0.000213	CcSEcCtD
Methotrexate—Dyspnoea—Doxorubicin—stomach cancer	1.5e-05	0.000212	CcSEcCtD
Methotrexate—Feeling abnormal—Epirubicin—stomach cancer	1.5e-05	0.000212	CcSEcCtD
Methotrexate—Somnolence—Doxorubicin—stomach cancer	1.49e-05	0.000211	CcSEcCtD
Methotrexate—Gastrointestinal pain—Epirubicin—stomach cancer	1.48e-05	0.00021	CcSEcCtD
Methotrexate—Dyspepsia—Doxorubicin—stomach cancer	1.48e-05	0.000209	CcSEcCtD
Methotrexate—Decreased appetite—Doxorubicin—stomach cancer	1.46e-05	0.000207	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Doxorubicin—stomach cancer	1.45e-05	0.000205	CcSEcCtD
Methotrexate—Fatigue—Doxorubicin—stomach cancer	1.45e-05	0.000205	CcSEcCtD
Methotrexate—Urticaria—Epirubicin—stomach cancer	1.44e-05	0.000204	CcSEcCtD
Methotrexate—Pain—Doxorubicin—stomach cancer	1.44e-05	0.000203	CcSEcCtD
Methotrexate—Abdominal pain—Epirubicin—stomach cancer	1.43e-05	0.000203	CcSEcCtD
Methotrexate—Body temperature increased—Epirubicin—stomach cancer	1.43e-05	0.000203	CcSEcCtD
Methotrexate—Feeling abnormal—Doxorubicin—stomach cancer	1.38e-05	0.000196	CcSEcCtD
Methotrexate—Gastrointestinal pain—Doxorubicin—stomach cancer	1.37e-05	0.000194	CcSEcCtD
Methotrexate—Hypersensitivity—Epirubicin—stomach cancer	1.34e-05	0.000189	CcSEcCtD
Methotrexate—Urticaria—Doxorubicin—stomach cancer	1.33e-05	0.000189	CcSEcCtD
Methotrexate—Abdominal pain—Doxorubicin—stomach cancer	1.33e-05	0.000188	CcSEcCtD
Methotrexate—Body temperature increased—Doxorubicin—stomach cancer	1.33e-05	0.000188	CcSEcCtD
Methotrexate—Asthenia—Epirubicin—stomach cancer	1.3e-05	0.000184	CcSEcCtD
Methotrexate—Pruritus—Epirubicin—stomach cancer	1.28e-05	0.000182	CcSEcCtD
Methotrexate—Diarrhoea—Epirubicin—stomach cancer	1.24e-05	0.000176	CcSEcCtD
Methotrexate—Hypersensitivity—Doxorubicin—stomach cancer	1.24e-05	0.000175	CcSEcCtD
Methotrexate—Asthenia—Doxorubicin—stomach cancer	1.21e-05	0.00017	CcSEcCtD
Methotrexate—Dizziness—Epirubicin—stomach cancer	1.2e-05	0.00017	CcSEcCtD
Methotrexate—Pruritus—Doxorubicin—stomach cancer	1.19e-05	0.000168	CcSEcCtD
Methotrexate—Vomiting—Epirubicin—stomach cancer	1.15e-05	0.000163	CcSEcCtD
Methotrexate—Diarrhoea—Doxorubicin—stomach cancer	1.15e-05	0.000163	CcSEcCtD
Methotrexate—Rash—Epirubicin—stomach cancer	1.14e-05	0.000162	CcSEcCtD
Methotrexate—Dermatitis—Epirubicin—stomach cancer	1.14e-05	0.000162	CcSEcCtD
Methotrexate—Headache—Epirubicin—stomach cancer	1.14e-05	0.000161	CcSEcCtD
Methotrexate—Dizziness—Doxorubicin—stomach cancer	1.11e-05	0.000157	CcSEcCtD
Methotrexate—Nausea—Epirubicin—stomach cancer	1.08e-05	0.000153	CcSEcCtD
Methotrexate—Vomiting—Doxorubicin—stomach cancer	1.07e-05	0.000151	CcSEcCtD
Methotrexate—Rash—Doxorubicin—stomach cancer	1.06e-05	0.00015	CcSEcCtD
Methotrexate—Dermatitis—Doxorubicin—stomach cancer	1.06e-05	0.00015	CcSEcCtD
Methotrexate—Headache—Doxorubicin—stomach cancer	1.05e-05	0.000149	CcSEcCtD
Methotrexate—Nausea—Doxorubicin—stomach cancer	9.98e-06	0.000141	CcSEcCtD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.2e-06	4.02e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ERCC2—stomach cancer	2.19e-06	4.01e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NOS3—stomach cancer	2.19e-06	4e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—HMOX1—stomach cancer	2.18e-06	3.98e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTGS2—stomach cancer	2.17e-06	3.97e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—MAPK1—stomach cancer	2.16e-06	3.95e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CDKN1A—stomach cancer	2.14e-06	3.91e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FYN—stomach cancer	2.13e-06	3.9e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—HRAS—stomach cancer	2.11e-06	3.86e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	2.11e-06	3.85e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PPARG—stomach cancer	2.11e-06	3.85e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CAV1—stomach cancer	2.11e-06	3.85e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—APOA1—stomach cancer	2.1e-06	3.84e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CD44—stomach cancer	2.1e-06	3.83e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PIK3CA—stomach cancer	2.09e-06	3.82e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—CDKN1A—stomach cancer	2.09e-06	3.82e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ALB—stomach cancer	2.08e-06	3.8e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SREBF2—stomach cancer	2.08e-06	3.8e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	2.08e-06	3.79e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PDHA1—stomach cancer	2.07e-06	3.78e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ECHS1—stomach cancer	2.07e-06	3.78e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—MTHFR—stomach cancer	2.06e-06	3.77e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—CDKN1B—stomach cancer	2.06e-06	3.76e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—RORA—stomach cancer	2.06e-06	3.76e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—TYMS—stomach cancer	2.06e-06	3.75e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ERCC2—stomach cancer	2.05e-06	3.75e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGS2—stomach cancer	2.05e-06	3.74e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PLAU—stomach cancer	2.04e-06	3.73e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—KRAS—stomach cancer	2.04e-06	3.73e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GSTM1—stomach cancer	2.03e-06	3.71e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPP2R1A—stomach cancer	2.03e-06	3.71e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—stomach cancer	2.02e-06	3.69e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PPARG—stomach cancer	2.02e-06	3.69e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.01e-06	3.68e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGFR2—stomach cancer	2e-06	3.66e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGS2—stomach cancer	2e-06	3.66e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—CAV1—stomach cancer	2e-06	3.65e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	2e-06	3.65e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.99e-06	3.64e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—APOA1—stomach cancer	1.99e-06	3.64e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NOS3—stomach cancer	1.99e-06	3.64e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GSTP1—stomach cancer	1.99e-06	3.63e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.96e-06	3.59e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—HMOX1—stomach cancer	1.96e-06	3.58e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TYMP—stomach cancer	1.95e-06	3.56e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—FADS1—stomach cancer	1.95e-06	3.56e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MTHFR—stomach cancer	1.93e-06	3.52e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPP2R1A—stomach cancer	1.93e-06	3.52e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ALDOB—stomach cancer	1.93e-06	3.52e-05	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PIK3CA—stomach cancer	1.91e-06	3.49e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.91e-06	3.49e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ERCC2—stomach cancer	1.91e-06	3.49e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—STAT3—stomach cancer	1.91e-06	3.49e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CAV1—stomach cancer	1.9e-06	3.47e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—CDKN1A—stomach cancer	1.9e-06	3.47e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PRKCB—stomach cancer	1.9e-06	3.47e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	1.9e-06	3.47e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—APOA1—stomach cancer	1.9e-06	3.47e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ALB—stomach cancer	1.9e-06	3.46e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GSTP1—stomach cancer	1.89e-06	3.45e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—PIK3CA—stomach cancer	1.88e-06	3.43e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.87e-06	3.42e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.87e-06	3.41e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—HMOX1—stomach cancer	1.86e-06	3.41e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—STAT3—stomach cancer	1.86e-06	3.41e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PPARG—stomach cancer	1.85e-06	3.39e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—TYMS—stomach cancer	1.85e-06	3.38e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IRS2—stomach cancer	1.84e-06	3.35e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GSTM1—stomach cancer	1.83e-06	3.34e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—MAPK3—stomach cancer	1.82e-06	3.33e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SREBF2—stomach cancer	1.82e-06	3.33e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS2—stomach cancer	1.82e-06	3.33e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.82e-06	3.32e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.82e-06	3.32e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—stomach cancer	1.82e-06	3.32e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—stomach cancer	1.82e-06	3.32e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—stomach cancer	1.81e-06	3.31e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.81e-06	3.31e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—RORA—stomach cancer	1.8e-06	3.29e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MTHFR—stomach cancer	1.8e-06	3.28e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ALOX5—stomach cancer	1.79e-06	3.27e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPP2R1A—stomach cancer	1.78e-06	3.26e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—MAPK3—stomach cancer	1.78e-06	3.25e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.78e-06	3.25e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CAV1—stomach cancer	1.78e-06	3.25e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOA1—stomach cancer	1.78e-06	3.24e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—MYC—stomach cancer	1.77e-06	3.24e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.77e-06	3.23e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—DPYD—stomach cancer	1.76e-06	3.22e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—TYMS—stomach cancer	1.76e-06	3.21e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTP1—stomach cancer	1.75e-06	3.2e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—stomach cancer	1.74e-06	3.17e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GSTM1—stomach cancer	1.74e-06	3.17e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—HRAS—stomach cancer	1.74e-06	3.17e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—MAPK1—stomach cancer	1.73e-06	3.17e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—EGFR—stomach cancer	1.73e-06	3.17e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—MYC—stomach cancer	1.73e-06	3.16e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—HMOX1—stomach cancer	1.73e-06	3.15e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	1.72e-06	3.15e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ERCC2—stomach cancer	1.72e-06	3.14e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—STAT3—stomach cancer	1.7e-06	3.1e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—MAPK1—stomach cancer	1.69e-06	3.1e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—EGFR—stomach cancer	1.69e-06	3.1e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALDOB—stomach cancer	1.69e-06	3.08e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6ST—stomach cancer	1.69e-06	3.08e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARG—stomach cancer	1.67e-06	3.05e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—stomach cancer	1.67e-06	3.04e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—stomach cancer	1.66e-06	3.03e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CAV1—stomach cancer	1.66e-06	3.03e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOA1—stomach cancer	1.65e-06	3.02e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.65e-06	3.01e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—KRAS—stomach cancer	1.64e-06	2.99e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ERCC2—stomach cancer	1.63e-06	2.98e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—TYMS—stomach cancer	1.63e-06	2.97e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.62e-06	2.96e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APC—stomach cancer	1.62e-06	2.96e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—MAPK3—stomach cancer	1.62e-06	2.96e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MTHFR—stomach cancer	1.62e-06	2.95e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTM1—stomach cancer	1.61e-06	2.94e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—KRAS—stomach cancer	1.6e-06	2.92e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.6e-06	2.92e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—stomach cancer	1.59e-06	2.91e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—stomach cancer	1.59e-06	2.9e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.58e-06	2.89e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SERPINE1—stomach cancer	1.58e-06	2.89e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—MYC—stomach cancer	1.58e-06	2.88e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALOX5—stomach cancer	1.57e-06	2.87e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.57e-06	2.87e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTT1—stomach cancer	1.56e-06	2.85e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DPYD—stomach cancer	1.54e-06	2.82e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—MAPK1—stomach cancer	1.54e-06	2.82e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—EGFR—stomach cancer	1.54e-06	2.82e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP2A6—stomach cancer	1.54e-06	2.81e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MTHFR—stomach cancer	1.54e-06	2.81e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—RHOA—stomach cancer	1.52e-06	2.79e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ERCC2—stomach cancer	1.51e-06	2.76e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.51e-06	2.76e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—stomach cancer	1.51e-06	2.76e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PIK3CA—stomach cancer	1.51e-06	2.75e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6R—stomach cancer	1.51e-06	2.75e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—stomach cancer	1.5e-06	2.75e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AKR1C3—stomach cancer	1.5e-06	2.74e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CAV1—stomach cancer	1.49e-06	2.72e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOA1—stomach cancer	1.49e-06	2.72e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—PIK3CA—stomach cancer	1.47e-06	2.69e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ENO1—stomach cancer	1.46e-06	2.67e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—stomach cancer	1.46e-06	2.66e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—KRAS—stomach cancer	1.46e-06	2.66e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARG—stomach cancer	1.46e-06	2.66e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—stomach cancer	1.44e-06	2.63e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.42e-06	2.6e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MTHFR—stomach cancer	1.42e-06	2.6e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CAV1—stomach cancer	1.42e-06	2.59e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOA1—stomach cancer	1.41e-06	2.58e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SERPINE1—stomach cancer	1.41e-06	2.57e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—HRAS—stomach cancer	1.39e-06	2.54e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTT1—stomach cancer	1.37e-06	2.49e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—HRAS—stomach cancer	1.36e-06	2.49e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—RHOA—stomach cancer	1.36e-06	2.48e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.35e-06	2.47e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP2A6—stomach cancer	1.35e-06	2.47e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—stomach cancer	1.35e-06	2.46e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—PIK3CA—stomach cancer	1.34e-06	2.44e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—stomach cancer	1.33e-06	2.44e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—stomach cancer	1.32e-06	2.4e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AKR1C3—stomach cancer	1.31e-06	2.4e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CAV1—stomach cancer	1.31e-06	2.4e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARG—stomach cancer	1.31e-06	2.39e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—stomach cancer	1.31e-06	2.39e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOA1—stomach cancer	1.31e-06	2.39e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—stomach cancer	1.3e-06	2.38e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CD44—stomach cancer	1.3e-06	2.37e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ENO1—stomach cancer	1.28e-06	2.34e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PIK3CA—stomach cancer	1.26e-06	2.3e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ERBB2—stomach cancer	1.26e-06	2.3e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.26e-06	2.3e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—stomach cancer	1.25e-06	2.29e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARG—stomach cancer	1.25e-06	2.27e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—HRAS—stomach cancer	1.24e-06	2.26e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PIK3CA—stomach cancer	1.23e-06	2.25e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—stomach cancer	1.23e-06	2.25e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.2e-06	2.19e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—stomach cancer	1.18e-06	2.16e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—stomach cancer	1.18e-06	2.15e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CDKN1B—stomach cancer	1.17e-06	2.13e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARG—stomach cancer	1.15e-06	2.11e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—stomach cancer	1.15e-06	2.09e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CD44—stomach cancer	1.13e-06	2.07e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—stomach cancer	1.13e-06	2.06e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PIK3CA—stomach cancer	1.12e-06	2.05e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—stomach cancer	1.12e-06	2.05e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPP2R1A—stomach cancer	1.1e-06	2.01e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—VEGFA—stomach cancer	1.09e-06	1.99e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTP1—stomach cancer	1.08e-06	1.97e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CDKN1A—stomach cancer	1.08e-06	1.97e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—stomach cancer	1.07e-06	1.96e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HMOX1—stomach cancer	1.07e-06	1.95e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—stomach cancer	1.04e-06	1.89e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—stomach cancer	1.03e-06	1.88e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—MAPK3—stomach cancer	1.03e-06	1.88e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PIK3CA—stomach cancer	1.02e-06	1.86e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—TYMS—stomach cancer	1e-06	1.83e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTM1—stomach cancer	9.93e-07	1.81e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—stomach cancer	9.92e-07	1.81e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—stomach cancer	9.79e-07	1.79e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—MAPK1—stomach cancer	9.79e-07	1.79e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PIK3CA—stomach cancer	9.78e-07	1.79e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPP2R1A—stomach cancer	9.65e-07	1.76e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—STAT3—stomach cancer	9.6e-07	1.75e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTP1—stomach cancer	9.46e-07	1.73e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HMOX1—stomach cancer	9.33e-07	1.71e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ERCC2—stomach cancer	9.33e-07	1.7e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—KRAS—stomach cancer	9.24e-07	1.69e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MAPK3—stomach cancer	9.17e-07	1.68e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—stomach cancer	9.07e-07	1.66e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PIK3CA—stomach cancer	8.97e-07	1.64e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MYC—stomach cancer	8.92e-07	1.63e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TYMS—stomach cancer	8.8e-07	1.61e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MTHFR—stomach cancer	8.77e-07	1.6e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MAPK1—stomach cancer	8.73e-07	1.59e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—EGFR—stomach cancer	8.72e-07	1.59e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTM1—stomach cancer	8.7e-07	1.59e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PIK3CA—stomach cancer	8.49e-07	1.55e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—KRAS—stomach cancer	8.24e-07	1.51e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—stomach cancer	8.21e-07	1.5e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ERCC2—stomach cancer	8.18e-07	1.49e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PIK3CA—stomach cancer	8.09e-07	1.48e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CAV1—stomach cancer	8.09e-07	1.48e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOA1—stomach cancer	8.07e-07	1.47e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HRAS—stomach cancer	7.86e-07	1.44e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.73e-07	1.41e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MTHFR—stomach cancer	7.69e-07	1.4e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PIK3CA—stomach cancer	7.57e-07	1.38e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARG—stomach cancer	7.11e-07	1.3e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CAV1—stomach cancer	7.09e-07	1.3e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOA1—stomach cancer	7.07e-07	1.29e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PIK3CA—stomach cancer	7.05e-07	1.29e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HRAS—stomach cancer	7e-07	1.28e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—stomach cancer	6.7e-07	1.22e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PIK3CA—stomach cancer	6.34e-07	1.16e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARG—stomach cancer	6.23e-07	1.14e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—stomach cancer	6.12e-07	1.12e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PIK3CA—stomach cancer	6.03e-07	1.1e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—stomach cancer	5.6e-07	1.02e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—stomach cancer	5.6e-07	1.02e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PIK3CA—stomach cancer	5.58e-07	1.02e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—stomach cancer	5.36e-07	9.79e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—stomach cancer	4.9e-07	8.96e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PIK3CA—stomach cancer	3.44e-07	6.29e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PIK3CA—stomach cancer	3.02e-07	5.51e-06	CbGpPWpGaD
